Cargando…
Effects of Sacubitril/Valsartan on resistant hypertension and myocardial work in hemodialysis patients
Growing evidences have confirmed the effect of Sacubitril/Valsartan (SV) on antihypertension and cardiac protection in general population. However, there was no prospective study about the effect and safety of SV on resistant hypertension and myocardial work in hemodialysis patients. In this single‐...
Autores principales: | Wang, Bin, Wang, Gui‐hua, Ding, Xiu‐xia, Tang, Hai‐xia, Zheng, Jing, Liu, Bi‐cheng, Zhang, Xiao‐liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924992/ https://www.ncbi.nlm.nih.gov/pubmed/35099841 http://dx.doi.org/10.1111/jch.14422 |
Ejemplares similares
-
Can myocardial work help in the therapy of resistant hypertension?
por: Tadic, Marijana, et al.
Publicado: (2022) -
Evaluation of left ventricular function by treadmill exercise stress echocardiography combined with layer‐specific strain technique in essential hypertension patients
por: Qingfeng, Zhang, et al.
Publicado: (2022) -
The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients
por: Zhao, Cong, et al.
Publicado: (2022) -
Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023) -
Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF
por: Guo, Yanhong, et al.
Publicado: (2022)